Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer

This article reviews the function of the phosphoinositide 3-kinase (PI3K)/AKT/mTOR pathway and the various classes of PI3K pathway inhibitors that have been developed to disrupt this pathway signaling for the treatment of hormone-receptor-positive breast cancer.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research